Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Assets (2019 - 2025)

10x Genomics (TXG) has disclosed Return on Assets for 7 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 15.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.04% through Dec 2025, up 15.0% year-over-year, with the annual reading at 0.04% for FY2025, 15.0% up from the prior year.
  • Return on Assets hit 0.04% in Q4 2025 for 10x Genomics, up from 0.08% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.04% in Q4 2025 to a low of 0.57% in Q1 2021.
  • Historically, Return on Assets has averaged 0.22% across 5 years, with a median of 0.17% in 2023.
  • Biggest YoY gain for Return on Assets was 49bps in 2021; the steepest drop was -49bps in 2021.
  • Year by year, Return on Assets stood at 0.06% in 2021, then plummeted by -183bps to 0.16% in 2022, then crashed by -63bps to 0.27% in 2023, then increased by 26bps to 0.2% in 2024, then soared by 79bps to 0.04% in 2025.
  • Business Quant data shows Return on Assets for TXG at 0.04% in Q4 2025, 0.08% in Q3 2025, and 0.09% in Q2 2025.